The Gut of Healthy Infants in the Community as a Reservoir of ESBL and Carbapenemase-Producing Bacteria.
Enterobacteriaceae
carbapenemase
extended-spectrum beta-lactamase
gut colonization
infants
multi-drug resistant
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
27 May 2020
27 May 2020
Historique:
received:
27
04
2020
revised:
19
05
2020
accepted:
21
05
2020
entrez:
31
5
2020
pubmed:
31
5
2020
medline:
31
5
2020
Statut:
epublish
Résumé
The recent rapid rise of multi-drug resistant Enterobacteriaceae (MDR-E) is threatening the treatment of common infectious diseases. Infections with such strains lead to increased mortality and morbidity. Using a cross-sectional study, we aimed to estimate the prevalence of gut colonization with extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae among healthy infants born in Pakistan, a setting with high incidence of MDR-E infections. Stool samples were collected from 104 healthy infants between the ages of 5 and 7 months. Enterobacteriaceae isolates were screened for resistance against several antimicrobial classes. Presence of ESBL and carbapenemase genes was determined using multiplex PCR. Sequence types were assigned to individual strains by multi-locus sequence typing. Phylogenetic analysis of Escherichia coli was done using the triplex PCR method. Forty-three percent of the infants were positive for ESBL-producing Enterobacteriaceae, the majority of which were E. coli. We identified several different ESBL E. coli sequence types most of which belonged to the phylogenetic group B2 (23%) or D (73%). The widespread colonization of infants in a developing country with ESBL-producing Enterobacteriaceae is concerning. The multiple sequence types and reported non-human sources support that multiple non-epidemic MDR lineages are circulating in Pakistan with healthy infants as a common reservoir.
Identifiants
pubmed: 32471150
pii: antibiotics9060286
doi: 10.3390/antibiotics9060286
pmc: PMC7345940
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Institute of Allergy and Infectious Diseases
ID : K12HD043494
Organisme : National Institute of Allergy and Infectious Diseases
ID : K08AI123524
Organisme : Duke University
ID : Duke Physician-Scientist Strong Start Award
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Références
BMC Genomics. 2008 Nov 26;9:560
pubmed: 19036134
Clin Perinatol. 2010 Sep;37(3):547-63
pubmed: 20813270
mBio. 2018 Feb 20;9(1):
pubmed: 29463654
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:42-52
pubmed: 18154527
Antimicrob Agents Chemother. 2010 Jun;54(6):2420-4
pubmed: 20308383
J Infect Dis. 2015 Dec 15;212(12):1862-8
pubmed: 25969564
Nature. 2014 May 8;509(7499):141-2
pubmed: 24805322
Appl Environ Microbiol. 2000 Oct;66(10):4555-8
pubmed: 11010916
Infect Immun. 1999 Feb;67(2):546-53
pubmed: 9916057
Infect Control Hosp Epidemiol. 2009 Jun;30(6):543-9
pubmed: 19435448
Clin Infect Dis. 2002 Mar 1;34(5):603-11
pubmed: 11807680
J Infect Dev Ctries. 2016 Sep 30;10(9):947-955
pubmed: 27694727
Antimicrob Agents Chemother. 1999 Mar;43(3):573-81
pubmed: 10049269
Clin Microbiol Infect. 2018 Mar;24(3):251-257
pubmed: 28830807
PLoS Med. 2013 Aug;10(8):e1001502
pubmed: 23976885
Paediatr Int Child Health. 2018 Nov;38(sup1):S3-S15
pubmed: 29790842
J Antimicrob Chemother. 2017 Aug 1;72(8):2145-2155
pubmed: 28541467
J Glob Health. 2011 Dec;1(2):154-70
pubmed: 23198116
Clin Microbiol Rev. 2014 Apr;27(2):241-63
pubmed: 24696435
J Infect Dis. 2005 Apr 1;191(7):1078-83
pubmed: 15747243
PLoS One. 2012;7(9):e46547
pubmed: 23029548
Infect Drug Resist. 2017 Jul 31;10:231-236
pubmed: 28814888
Pediatr Infect Dis J. 2009 Jan;28(1 Suppl):S10-8
pubmed: 19106757
J Infect Dis. 2018 Jan 17;217(3):443-450
pubmed: 29126173
Infect Immun. 2000 Apr;68(4):2096-101
pubmed: 10722606
J Perinatol. 2015 Nov;35(11):907-12
pubmed: 26507147
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5694-9
pubmed: 24706808
Gut Pathog. 2017 Apr 20;9:19
pubmed: 28439298
Ann Clin Microbiol Antimicrob. 2015 Apr 12;14:23
pubmed: 25890291
Antimicrob Agents Chemother. 2011 Nov;55(11):5370-3
pubmed: 21844325
Environ Sci Technol. 2012 Aug 21;46(16):8672-9
pubmed: 22823142
J Pak Med Assoc. 2016 Aug;66(8):999-1004
pubmed: 27524536
Antimicrob Agents Chemother. 2002 Dec;46(12):3739-43
pubmed: 12435670
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Int J Health Plann Manage. 2002 Jan-Mar;17(1):23-40
pubmed: 11963441
Microb Drug Resist. 2015 Feb;21(1):59-64
pubmed: 25127253